|
|
|
|
| LEADER |
01066cam a2200253 7i4500 |
| 001 |
0000054276 |
| 005 |
20220204090000.0 |
| 008 |
170512s2016 eng |
| 040 |
|
|
|a TSAM
|
| 090 |
0 |
0 |
|a HG4028.S7
|b YUM 2016
|
| 100 |
1 |
|
|a Yu, Meng Hui
|e author
|
| 245 |
1 |
0 |
|a IPO underpricing of pharmaceutical companies in China between 2010 and 2015 [
|m Dissertation]
|c Yu Meng Hui.
|
| 264 |
|
1 |
|a Nilai, Negeri Sembilan:
|b INTI International University,
|c 2016.
|
| 300 |
|
|
|a 115 pages;
|c 29 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 500 |
|
|
|a Master of Business Administration Code: MBA224
|
| 501 |
0 |
0 |
|a Faculty of Business, Communications and Law
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
1 |
|a This study focuses on the pharmaceutical industry which is a knowledge-based, technology-intensive industry and has become one of the leading industries in China
|
| 650 |
1 |
0 |
|a Management --
|x Going Public (Securities) --
|z China
|
| 650 |
1 |
0 |
|a Management
|
| 901 |
|
|
|u http://eprints.intimal.edu.my
|